Literature DB >> 8478036

Insulin resistance in young salt-sensitive normotensive subjects.

A M Sharma1, U Schorr, A Distler.   

Abstract

Insulin resistance has been demonstrated in patients with essential hypertension, and insulin-mediated sodium retention is believed to contribute to hypertension in these individuals. Recently, a hyperinsulinemic response to an oral glucose load has been found in salt-sensitive normotensive subjects, suggesting that insulin resistance may be present in these hypertension-prone individuals before the development of hypertension. In the present study, we examined the relation between insulin sensitivity and blood pressure response to salt intake in young, lean normotensive subjects on a high and a low salt diet. Insulin sensitivity was estimated by the "insulin suppression test," i.e., by measuring the plasma glucose and insulin concentrations achieved during a 180-minute infusion of somatostatin, insulin, and glucose in 18 healthy male volunteers (age, 21-28 years) given a standardized low salt diet (20 mmol/day) for 2 weeks, supplemented by either 220 mmol of NaCl per day or placebo in a single-blind randomized order for 1 week each. We defined salt sensitivity as a significant decrease in mean arterial blood pressure (> 3 mm Hg [p < 0.05]) measured for 60 minutes at 1-minute intervals on the low salt diet. By this definition, seven of the 18 subjects were salt sensitive. Although insulin infusion resulted in similar plasma insulin levels (approximately 50 milliunits/L) in both groups, concomitant glucose infusion resulted in plasma glucose levels that were more than 50% higher in the salt-sensitive than in the salt-resistant group (p < 0.005 by two-way analysis of variance).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478036     DOI: 10.1161/01.hyp.21.3.273

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

Review 1.  Nonhypertensive cardiac effects of a high salt diet.

Authors:  Gang Hu; Qing Qiao; Jaakko Tuomilehto
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

2.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

3.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

4.  Low ethanol intake prevents salt-induced hypertension in WKY rats.

Authors:  Sudesh Vasdev; Vicki Gill; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2006-05-10       Impact factor: 3.396

5.  PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.

Authors:  Charity Nofziger; Lihong Chen; Michael Anne Shane; Chari D Smith; Kathleen K Brown; Bonnie L Blazer-Yost
Journal:  Pflugers Arch       Date:  2005-09-17       Impact factor: 3.657

6.  Further evidence for reduced beta 2-adrenoceptor expression and modification of its density at a level beyond gene expression.

Authors:  P Kotanko; O Höglinger; A Binder; F Skrabal
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

7.  Effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertension.

Authors:  Rajesh Garg; Bei Sun; Jonathan Williams
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

8.  Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats.

Authors:  Sudesh Vasdev; Vicki Gill; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

9.  Salt restriction among hypertensive patients: modest blood pressure effect and no adverse effects.

Authors:  Eivind Meland; Aase Aamland
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

10.  Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.